Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection - PubMed (original) (raw)
Review
. 2007 Jul-Aug;17(4):253-76.
doi: 10.1002/rmv.535.
Affiliations
- PMID: 17579921
- DOI: 10.1002/rmv.535
Review
Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection
Aileen Kenneson et al. Rev Med Virol. 2007 Jul-Aug.
Abstract
We reviewed studies that reported results of systematic cytomegalovirus (CMV) screening on fetuses and/or live-born infants. The overall birth prevalence of congenital CMV infection was 0.64%, but varied considerably among different study populations. About 11% of live-born infants with congenital CMV infection were symptomatic, but the inter-study differences in definitions of symptomatic cases limit the interpretation of these data. Non-white race, low socioeconomic status (SES), premature birth, and neonatal intensive care unit admittance were risk factors for congenital CMV infection. Birth prevalence increased with maternal CMV seroprevalence. Maternal seroprevalence accounted for 29% of the variance in birth prevalence between study populations. Maternal seroprevalence and birth prevalence were both higher in study populations that were ascertained at birth rather than in the prenatal period. Thus, timing of ascertainment should be considered when interpreting birth prevalence estimates. Birth prevalence was inversely correlated with mean maternal age, but this relationship was not significant when controlling for maternal seroprevalence. The rate of transmission to infants born to mothers who had a primary infection or a recurrent infection during pregnancy was 32% and 1.4%, respectively. Possible maternal primary infections (i.e. seropositive mother with CMV IgM) resulted in congenital infections about 20% of the time, but are likely to represent a mixture of primary and recurrent infections. In summary, CMV is a common congenital infection worldwide that can lead to permanent disabilities. There is an urgent need for interventions that can reduce the substantial burden of this often overlooked disease.
Similar articles
- CMV seroconversion in pregnants and the incidence of congenital CMV infection.
Satilmiş A, Güra A, Ongun H, Mendilcioğlu I, Colak D, Oygür N. Satilmiş A, et al. Turk J Pediatr. 2007 Jan-Mar;49(1):30-6. Turk J Pediatr. 2007. PMID: 17479641 - Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection.
Cannon MJ, Schmid DS, Hyde TB. Cannon MJ, et al. Rev Med Virol. 2010 Jul;20(4):202-13. doi: 10.1002/rmv.655. Rev Med Virol. 2010. PMID: 20564615 Review. - Perinatal or early-postnatal cytomegalovirus infection in preterm infants under 34 weeks gestation born to CMV-seropositive mothers within a high-seroprevalence population.
Mussi-Pinhata MM, Yamamoto AY, do Carmo Rego MA, Pinto PC, da Motta MS, Calixto C. Mussi-Pinhata MM, et al. J Pediatr. 2004 Nov;145(5):685-8. doi: 10.1016/j.jpeds.2004.07.025. J Pediatr. 2004. PMID: 15520780 - Maternal antibodies against cytomegalovirus in pregnancy and the risk of fetal death and low birth weight.
Eskild A, Jenum PA, Bruu AL. Eskild A, et al. Acta Obstet Gynecol Scand. 2005 Nov;84(11):1035-41. doi: 10.1111/j.0001-6349.2005.00796.x. Acta Obstet Gynecol Scand. 2005. PMID: 16232169 - Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV.
Hyde TB, Schmid DS, Cannon MJ. Hyde TB, et al. Rev Med Virol. 2010 Sep;20(5):311-26. doi: 10.1002/rmv.659. Rev Med Virol. 2010. PMID: 20645278 Review.
Cited by
- Seroprevalent study of cytomegalovirus infection in the regions of Jharkhand.
Sundi A, Roopa N, Gupta P, Irfan S, Kar TK. Sundi A, et al. J Family Med Prim Care. 2024 Sep;13(9):4066-4070. doi: 10.4103/jfmpc.jfmpc_259_24. Epub 2024 Sep 11. J Family Med Prim Care. 2024. PMID: 39464971 Free PMC article. - The frequency of cytomegalovirus non-ELR UL146 genotypes in neonates with congenital CMV disease is comparable to strains in the background population.
Berg C, Rosenkilde MM, Benfield T, Nielsen L, Sundelin T, Lüttichau HR. Berg C, et al. BMC Infect Dis. 2021 Apr 26;21(1):386. doi: 10.1186/s12879-021-06076-w. BMC Infect Dis. 2021. PMID: 33902487 Free PMC article. - The immunological underpinnings of vaccinations to prevent cytomegalovirus disease.
McCormick AL, Mocarski ES. McCormick AL, et al. Cell Mol Immunol. 2015 Mar;12(2):170-9. doi: 10.1038/cmi.2014.120. Epub 2014 Dec 29. Cell Mol Immunol. 2015. PMID: 25544503 Free PMC article. Review. - Laboratory testing and diagnostic coding for cytomegalovirus among privately insured infants in the United States: a retrospective study using administrative claims data.
Leung J, Cannon MJ, Grosse SD, Bialek SR. Leung J, et al. BMC Pediatr. 2013 Jun 7;13:90. doi: 10.1186/1471-2431-13-90. BMC Pediatr. 2013. PMID: 23758752 Free PMC article. - Detection of Genotype-Specific Antibody Responses to Glycoproteins B and H in Primary and Non-Primary Human Cytomegalovirus Infections by Peptide-Based ELISA.
Zavaglio F, Fiorina L, Suárez NM, Fornara C, De Cicco M, Cirasola D, Davison AJ, Gerna G, Lilleri D. Zavaglio F, et al. Viruses. 2021 Mar 3;13(3):399. doi: 10.3390/v13030399. Viruses. 2021. PMID: 33802390 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical